L

LYRA

Lyra Therapeutics, Inc.

0.10

0.00+2.94%
After Hours: 0.1007  -0.00  -4.10%19:59 05/07 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Total Assets

66.35M

142.60M

109.97M

54.87M

80.83M

Total Current Assets

43.02M

104.82M

100.83M

47.92M

75.92M

Total Non Current Assets

23.32M

37.78M

9.14M

6.95M

4.91M

Total Liabilities

54.75M

53.18M

29.21M

20.55M

6.34M

Total Current Liabilities

12.63M

19.60M

14.47M

18.25M

4.88M

Total Non Current Liabilities

42.12M

33.58M

14.74M

2.31M

1.45M

Total Equity

11.59M

89.42M

80.75M

34.32M

74.49M

Total Stockholders Equity

11.59M

89.42M

80.75M

34.32M

74.49M

Minority Interest

--

--

--

--

--

Total Liabilities & Shareholders Equity

66.35M

142.60M

109.97M

54.87M

80.83M

Total Common Shares Outstanding

65.52M

57.21M

31.83M

13.01M

12.93M

Total Preferred Shares Outstanding

--

--

--

--

--